Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × toripalimab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumor 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Locally Advanced Rectal Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Solid Tumors 1 Advanced Malignant Solid Tumors 1 Advanced Breast Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

elacestrant 2 Fulvestrant 2 trastuzumab deruxtecan 1 toripalimab 1 ribociclib 1 palbociclib 1 exemestane 1 abemaciclib 1 Selective Estrogen Receptor Modulators 1 RAD1901 1 Letrozole 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Anastrozole 1 Alpelisib 1 AZD9833 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡